Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Control of T cell viability.

Philippa Marrack1, John Kappler

  • 1Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, and Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206, USA. marrackp@njc.org

Annual Review of Immunology
|March 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MHC heterozygosity limits T cell receptor variability in CD4 T cells.

Science immunology·2024
Same author

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.

ERJ open research·2023
Same author

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.

medRxiv : the preprint server for health sciences·2023
Same author

The broad spectrum of pathogenic autoreactivity.

Nature reviews. Immunology·2022
Same author

The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.

International journal of molecular sciences·2022
Same author

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity.

Frontiers in immunology·2022

T cell viability differs by cell type and status. Naive T cells rely on Bcl-2/Bim, while activated T cells use intrinsic and extrinsic pathways. Memory T cell survival also varies between CD4+ and CD8+ subtypes.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • T cell viability is crucial for immune responses.
  • Different T cell subsets (naive, activated, memory) have distinct survival mechanisms.

Purpose of the Study:

  • To elucidate the diverse factors influencing T cell viability.
  • To differentiate the survival pathways of naive, activated, and memory T cells.

Main Methods:

  • Review of existing literature on T cell survival pathways.
  • Analysis of molecular mechanisms including Bcl-2 family proteins, cytokines (IL-7, IL-15), and cell surface receptors (MHC, Fas, TCR).

Main Results:

  • Naive T cells undergo apoptosis via Bcl-2/Bim, with survival promoted by IL-7 and MHC.
  • Activated T cells exhibit both extrinsic (e.g., Fas) and intrinsic (Bcl-2 family) death pathways.

Related Experiment Videos

  • CD8+ memory T cells are sustained by IL-15 and IL-7, whereas CD4+ memory T cell regulation is less understood, involving IL-7 and TCR signaling.

    • Conclusions:

    • T cell viability is tightly regulated by cell-specific intrinsic and extrinsic factors.
    • Understanding these pathways is key to manipulating T cell populations for therapeutic purposes.